Differential expression of interleukin 1α by Thy‐1+ and Thy‐1 lung fibroblast subpopulations: Enhancement of interleukin 1α production by tumor necrosis factor‐α

Richard P. Phipps, Clare Baecher, John G. Frelinger, David P. Penney, Peter Keng, Deborah Brown

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

The purpose of this investigation was to determine whether subpopulations of murine lung fibroblasts produced interleukin 1 (IL 1). We previously identified two major populations of pulmonary fibroblasts based on the presence or absence of Thy‐1. Thy‐1+ and Thy‐1 subsets synsthesize fibronectin and type I and III collagen, but only the Thy‐1 population displays class II major histocompatibility complex antigens after stimulation with interferon‐γ and presents antigen to T helper clones. Interestingly, in the current study we determined that only Thy‐1 fibroblast lines and clones synthesized IL 1. Although constitutive production was low, tumor necrosis factor ‐α (TNF‐α) stimulated 5‐20‐fold increases in IL 1 production in Thy‐1 fibroblasts. The Thy‐1+ fibroblasts did not produce IL 1 even after TNF‐α treatment. Northern blot analysis of TNF‐α treated cells revealed that in the Thy‐1 subset increased mRNA levels for IL 1α were detected, while IL 1β mRNA was not detected. Furthermore, IL 1 activity from TNF‐α‐treated Thy‐1 fibroblast membranes and supernatants was completely neutralized by IL 1α‐specific antibodies. These observations support the hypothesis that the antigen‐presenting Thy‐1 subset is important for promoting the inflammation associated with pulmonary fibrosis. In addition, the existence of functional subsets of lung fibroblasts is further substantiated by differential expression of IL 1.

Original languageEnglish (US)
Pages (from-to)1723-1727
Number of pages5
JournalEuropean Journal of Immunology
Volume20
Issue number8
DOIs
StatePublished - Aug 1990

Fingerprint

Interleukin-1
Tumor Necrosis Factor-alpha
Fibroblasts
Lung
Clone Cells
Messenger RNA
Collagen Type III
Pulmonary Fibrosis
Viral Tumor Antigens
Histocompatibility Antigens Class II
Collagen Type I
Major Histocompatibility Complex
Fibronectins
Northern Blotting
Interferons
Population
Inflammation
Membranes
Antibodies

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Differential expression of interleukin 1α by Thy‐1+ and Thy‐1 lung fibroblast subpopulations : Enhancement of interleukin 1α production by tumor necrosis factor‐α. / Phipps, Richard P.; Baecher, Clare; Frelinger, John G.; Penney, David P.; Keng, Peter; Brown, Deborah.

In: European Journal of Immunology, Vol. 20, No. 8, 08.1990, p. 1723-1727.

Research output: Contribution to journalArticle

@article{2b7202f4449440c6928f6d5ea6bbbe64,
title = "Differential expression of interleukin 1α by Thy‐1+ and Thy‐1− lung fibroblast subpopulations: Enhancement of interleukin 1α production by tumor necrosis factor‐α",
abstract = "The purpose of this investigation was to determine whether subpopulations of murine lung fibroblasts produced interleukin 1 (IL 1). We previously identified two major populations of pulmonary fibroblasts based on the presence or absence of Thy‐1. Thy‐1+ and Thy‐1− subsets synsthesize fibronectin and type I and III collagen, but only the Thy‐1− population displays class II major histocompatibility complex antigens after stimulation with interferon‐γ and presents antigen to T helper clones. Interestingly, in the current study we determined that only Thy‐1− fibroblast lines and clones synthesized IL 1. Although constitutive production was low, tumor necrosis factor ‐α (TNF‐α) stimulated 5‐20‐fold increases in IL 1 production in Thy‐1− fibroblasts. The Thy‐1+ fibroblasts did not produce IL 1 even after TNF‐α treatment. Northern blot analysis of TNF‐α treated cells revealed that in the Thy‐1− subset increased mRNA levels for IL 1α were detected, while IL 1β mRNA was not detected. Furthermore, IL 1 activity from TNF‐α‐treated Thy‐1− fibroblast membranes and supernatants was completely neutralized by IL 1α‐specific antibodies. These observations support the hypothesis that the antigen‐presenting Thy‐1− subset is important for promoting the inflammation associated with pulmonary fibrosis. In addition, the existence of functional subsets of lung fibroblasts is further substantiated by differential expression of IL 1.",
author = "Phipps, {Richard P.} and Clare Baecher and Frelinger, {John G.} and Penney, {David P.} and Peter Keng and Deborah Brown",
year = "1990",
month = "8",
doi = "10.1002/eji.1830200815",
language = "English (US)",
volume = "20",
pages = "1723--1727",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "8",

}

TY - JOUR

T1 - Differential expression of interleukin 1α by Thy‐1+ and Thy‐1− lung fibroblast subpopulations

T2 - Enhancement of interleukin 1α production by tumor necrosis factor‐α

AU - Phipps, Richard P.

AU - Baecher, Clare

AU - Frelinger, John G.

AU - Penney, David P.

AU - Keng, Peter

AU - Brown, Deborah

PY - 1990/8

Y1 - 1990/8

N2 - The purpose of this investigation was to determine whether subpopulations of murine lung fibroblasts produced interleukin 1 (IL 1). We previously identified two major populations of pulmonary fibroblasts based on the presence or absence of Thy‐1. Thy‐1+ and Thy‐1− subsets synsthesize fibronectin and type I and III collagen, but only the Thy‐1− population displays class II major histocompatibility complex antigens after stimulation with interferon‐γ and presents antigen to T helper clones. Interestingly, in the current study we determined that only Thy‐1− fibroblast lines and clones synthesized IL 1. Although constitutive production was low, tumor necrosis factor ‐α (TNF‐α) stimulated 5‐20‐fold increases in IL 1 production in Thy‐1− fibroblasts. The Thy‐1+ fibroblasts did not produce IL 1 even after TNF‐α treatment. Northern blot analysis of TNF‐α treated cells revealed that in the Thy‐1− subset increased mRNA levels for IL 1α were detected, while IL 1β mRNA was not detected. Furthermore, IL 1 activity from TNF‐α‐treated Thy‐1− fibroblast membranes and supernatants was completely neutralized by IL 1α‐specific antibodies. These observations support the hypothesis that the antigen‐presenting Thy‐1− subset is important for promoting the inflammation associated with pulmonary fibrosis. In addition, the existence of functional subsets of lung fibroblasts is further substantiated by differential expression of IL 1.

AB - The purpose of this investigation was to determine whether subpopulations of murine lung fibroblasts produced interleukin 1 (IL 1). We previously identified two major populations of pulmonary fibroblasts based on the presence or absence of Thy‐1. Thy‐1+ and Thy‐1− subsets synsthesize fibronectin and type I and III collagen, but only the Thy‐1− population displays class II major histocompatibility complex antigens after stimulation with interferon‐γ and presents antigen to T helper clones. Interestingly, in the current study we determined that only Thy‐1− fibroblast lines and clones synthesized IL 1. Although constitutive production was low, tumor necrosis factor ‐α (TNF‐α) stimulated 5‐20‐fold increases in IL 1 production in Thy‐1− fibroblasts. The Thy‐1+ fibroblasts did not produce IL 1 even after TNF‐α treatment. Northern blot analysis of TNF‐α treated cells revealed that in the Thy‐1− subset increased mRNA levels for IL 1α were detected, while IL 1β mRNA was not detected. Furthermore, IL 1 activity from TNF‐α‐treated Thy‐1− fibroblast membranes and supernatants was completely neutralized by IL 1α‐specific antibodies. These observations support the hypothesis that the antigen‐presenting Thy‐1− subset is important for promoting the inflammation associated with pulmonary fibrosis. In addition, the existence of functional subsets of lung fibroblasts is further substantiated by differential expression of IL 1.

UR - http://www.scopus.com/inward/record.url?scp=0025113198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025113198&partnerID=8YFLogxK

U2 - 10.1002/eji.1830200815

DO - 10.1002/eji.1830200815

M3 - Article

C2 - 1976521

AN - SCOPUS:0025113198

VL - 20

SP - 1723

EP - 1727

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 8

ER -